Shirley Y. Su, MBBS, FRACS
Department of Head and Neck Surgery, Division of Surgery
About Dr. Su
Dr. Shirley Y. Su is Associate Professor in the Department of Head and Neck Surgery at The University of Texas MD Anderson Cancer Center in Houston, Texas. She also serves as adjunct Associate Professor in the Department of Neurosurgery. Dr. Su is Dual Board Certified with the American Board of Otolaryngology - Head and Neck Surgery and the Royal Australasian College of Surgeons. She completed two fellowships; Head and Neck Surgery at the University of Texas MD Anderson Cancer Center and Open and Endoscopic Skull Base Surgery at the University of Pittsburgh Medical Center. Dr. Su's clinical expertise is in the endoscopic and open surgery management of complex benign and malignant tumors of the sinus, nasal cavity, nasopharynx, and skull base. Her research interests are centered around improving oncological and functional outcomes for patients treated for skull base malignancies. She is the Investigator on several prospective studies evaluating novel treatment for sinonasal cancers and to reduce the side effects of treatment. Dr. Su is the Vice-Chair of the Section of Skull Base Surgery for the American Head and Neck Society and the immediate past Chair of the Skull Base Surgery Committee for the American Academy of Otolaryngology Head and Neck Society. She is a Director at Large of the North American Skull Base Society and a member of the Editorial Board of the Journal of Neurological Surgery Part B. She has been invited to present at multiple national and international meetings on the topic of sinonasal tumors, head and neck tumors and skull base surgery. Dr. Su has been recognized for excellence in clinic care with a Top 1% Award.
<br/>
Meet Shirley Su, M.B.B.S.
Skull base tumor specialist Shirley Su on treatment for these rare tumors
Present Title & Affiliation
Primary Appointment
Associate Professor, Department of Head and Neck Surgery, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX
Associate Professor, Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, Texas
Dual/Joint/Adjunct Appointment
Associate Professor, Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas
Associate Professor, Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, Texas
Clinical Assistant Professor, Department of Otolaryngology, The University of Texas Medical Branch Galveston, Houston, TX
Research Interests
<p>Minimally invasive surgery, cancers of the nose, sinuses and cranial base.</p>
Education & Training
Degree-Granting Education
| 2000 | Monash University, Melbourne, AU, Medicine, MBBS |
Postgraduate Training
| 2012-2013 | Clinical Fellowship, Endoscopic and Open Cranial Base Surgery; Clinical Instructor, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania |
| 2011-2012 | Clinical Fellowship, Head and Neck Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas |
| 2007-2011 | Clinical Residency, Advanced Surgical Training in Otolaryngology, Royal Australasian College of Surgeons, East Melbourne |
| 2005-2007 | Clinical Residency, Advanced Surgical Training in General Surgery, Royal Australasian College of Surgeons, East Melbourne |
| 2002-2005 | Basic Surgical Training, Royal Australasian College of Surgeons, East Melbourne |
| 2001-2002 | Clinical Internship, General, Monash Medical Center, Melbourne |
Board Certifications
| 2021 | American Board of Otolaryngology- Head and Neck Surgery |
| 2011 | Royal Australasian College of Surgeons |
Experience & Service
Academic Appointments
Assistant Professor, Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, TX, 2017 - 2019
Assistant Professor, Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, 2013 - 2019
Instructor, Department of Otolaryngology, University of Pittsburgh School of Medicine, Pittsburgh, PA, 2012 - 2013
Consultant Surgeon, Department of Otolaryngology, Royal Children's Hospital, Melbourne, 2011 - 2011
Administrative Appointments/Responsibilities
Innovation Officer, Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, 2021 - Present
Other Appointments/Responsibilities
Chair, MD Anderson Cancer Center Skull Base Research Group, Houston, TX, 2015 - 2021
Institutional Committee Activities
Member, Credentials Committee of the Medical Staff, 2020 - 2023
Member, Division of Surgery Innovation Committee, 2020 - Present
Member, Graves Disease Program Development Committee, 2018 - 2020
Associate Scientific Member, Institutional Review Board 1, 2017 - 2020
Alternate Member, Clinical Effectiveness Subcommittee, 2017 - 2024
Member, Algorithm - Cataract Screening Development, 2017 - 2017
Chair, Skull Base Multidisciplinary Meeting, 2015 - 2020
Team Member, Inpatient Operations Steering Committee (IOSC), 2014 - 2015
Honors & Awards
| Chinese Health Foundation of Australia Award, Chinese Health Foundation of Australia | |
| Health Promotion Prize for project: "The Prevention of diabetes in Women with a History of Gestational Diabetes", VicHealth | |
| Commonwealth Foundation Medical Electives Scholarship, Commonwealth Foundation Medical Electives | |
| Award for Notable Contribution, Young Achievement Australia | |
| Top 1% Award - Based on Consumer Assessment of Healthcare Providers and Systems scores for “top 1% of physicians nationally on care experience”, The University of Texas MD Anderson Cancer Center | |
| Service Award, American Head and Neck Society |
Selected Publications
Peer-Reviewed Articles
- Shah JP, Levyn H, Valero C, Adilbay D, Eagan A, Zheng J, Gonen M, Cohen M, Patel S, Ganly I, Pai P, Castelnuovo P, Gao FJ, Piazza C, Nicolai P, Panizza B, Bowman J, Barnett C, Kowalski LP, Toledo R, Fliss DM, DeAlmeida J, Witterick I, Herman P, Fontanella W, Aniceto GS, Hosal S, Ozer S, Iyer S, Harvey R, Leemans CR, Hendrickx JJ, Figari M, Boccalatte L, Nibu KI, Clarke P, Rennie C, Ming ZY, Cernea C, Goncalves S, Schlosser R, Dias F, Sargi Z, Ahmed S, Golusinski W, Kim SH, Su SY, Raza SM, DeMonte F, Hanna E. Skull base surgery for malignant tumors: The 2nd international collaborative study (1995-2015). Head Neck. e-Pub 2024. PMID: 38770972.
- Yaniv D, Niccolai LM, Wefel JS, Sullaway CM, Hanna EY, Fuller CD, Haroun KB, Phan J, Su SY. Neurocognitive Functioning of Patients with Sinonasal and Nasopharyngeal Cancers Treated with Multimodality Therapy. J Neurol Surg B Skull Base. e-Pub 2024. PMID: None.
- Zhao J, Jiang X, Hanna E, Su SY, Moreno A, Gunn B, Frank SJ, Ferrarotto R, Ning J, Esmaeli B. Orbital and periocular complications in patients with sinonasal tumours with orbital invasion. Br J Ophthalmol 108(3):465-470, 2024. e-Pub 2024. PMID: 36707226.
- Ramesh U, Contrera KJ, Shakibai N, Su SY, Brahimaj B, Roberts D, Williams MD, Ferrarotto R, Phan J, Gunn GB, Raza S, DeMonte F, Hanna EY. Sinonasal NUT carcinoma: A consecutive case series and systematic review. Head Neck 46(1):29-36, 2024. e-Pub 2023. PMID: 37853958.
- Contrera KJ, Phan J, Waguespack SG, Aldehaim M, Wang X, Lim TY, Roberts DB, Fuller CD, Spiotto MT, Raza SM, DeMonte F, Hanna EY, Su SY. Prevalence of pituitary hormone dysfunction following radiotherapy for sinonasal and nasopharyngeal malignancies. Head Neck 45(10):2525-2532, 2023. e-Pub 2023. PMID: 37534890.
- Schur S, Hanna EY, Su SY, Kupferman ME, DeMonte F, Raza SM. Long-term oncological outcomes for endoscopic endonasal versus open surgical approaches for anatomically matched, locally advanced stage T4 sinonasal malignancies with skull base involvement. J Neurosurg:1-8. e-Pub 2023. PMID: 37877981.
- Kuan EC, Wang EW, Adappa ND, Beswick DM, London NR, Su SY, Wang MB, Abuzeid WM, Alexiev B, Alt JA, Antognoni P, Alonso-Basanta M, Batra PS, Bhayani M, Bell D, Bernal-Sprekelsen M, Betz CS, Blay JY, Bleier BS, Bonilla-Velez J, Callejas C, Carrau RL, Casiano RR, Castelnuovo P, Chandra RK, Chatzinakis V, Chen SB, Chiu AG, Choby G, Chowdhury NI, Citardi MJ, Cohen MA, Dagan R, Dalfino G, Dallan I, Dassi CS, de Almeida J, Dei Tos AP, DelGaudio JM, Ebert CS, El-Sayed IH, Eloy JA, Evans JJ, Fang CH, Farrell NF, Ferrari M, Fischbein N, Folbe A, Fokkens WJ, Fox MG, Lund VJ, Gallia GL, Gardner PA, Geltzeiler M, Georgalas C, Getz AE, Govindaraj S, Gray ST, Grayson JW, Gross BA, Grube JG, Guo R, Ha PK, Halderman AA, Hanna EY, Harvey RJ, Hernandez SC, Holtzman AL, Hopkins C, Huang Z, Huang Z, Humphreys IM, Hwang PH, Iloreta AM, Ishii M, Ivan ME, Jafari A, Kennedy DW, Khan M, Kimple AJ, Kingdom TT, Knisely A, Kuo YJ, Lal D, Lamarre ED, Lan MY, Le H, Lechner M, Lee NY, Lee JK, Lee VH, Levine CG, Lin JC, Lin DT, Lobo BC, Locke T, Luong AU, Magliocca KR, Markovic SN, Matnjani G, McKean EL, Meço C, Mendenhall WM, Michel L, Na'ara S, Nicolai P, Nuss DW, Nyquist GG, Oakley GM, Omura K, Orlandi RR, Otori N, Papagiannopoulos P, Patel ZM, Pfister DG, Phan J, Psaltis AJ, Rabinowitz MR, Ramanathan M, Rimmer R, Rosen MR, Sanusi O, Sargi ZB, Schafhausen P, Schlosser RJ, Sedaghat AR, Senior BA, Shrivastava R, Sindwani R, Smith TL, Smith KA, Snyderman CH, Solares CA, Sreenath SB, Stamm A, Stölzel K, Sumer B, Surda P, Tajudeen BA, Thompson LDR, Thorp BD, Tong CCL, Tsang RK, Turner JH, Turri-Zanoni M, Udager AM, van Zele T, VanKoevering K, Welch KC, Wise SK, Witterick IJ, Won TB, Wong SN, Woodworth BA, Wormald PJ, Yao WC, Yeh CF, Zhou B, Palmer JN. International consensus statement on allergy and rhinology: Sinonasal tumors. Int Forum Allergy Rhinol. e-Pub 2023. PMID: 37658764.
- Contrera KJ, Shakibai N, Su SY, Gule-Monroe MK, Roberts D, Brahimaj B, Williams MD, Ferrarotto R, Phan J, Gunn B, Raza S, DeMonte F, Hanna EY. Impact of Clinical Factors and Treatments on SMARCB1 (INI-1)-Deficient Sinonasal Carcinoma. Otolaryngol Head Neck Surg 169(2):435-440, 2023. e-Pub 2023. PMID: 36856048.
- Bahig H, Ehab HY, Garden AS, Ng SP, Frank SJ, Nguyen T, Gunn GB, Rosenthal DI, Fuller CD, Ferrarotto R, Bell D, Su SY, Phan J. Long-term outcomes of modern multidisciplinary management of sinonasal cancers: The M. D. Anderson experience. Head Neck 45(7):1692-1703, 2023. e-Pub 2023. PMID: 37165701.
- Contrera KJ, Tam S, Pytynia K, Diaz EM, Hessel AC, Goepfert RP, Lango M, Su SY, Myers JN, Weber RS, Eguia A, Pisters PWT, Adair DK, Nair AS, Rosenthal DI, Mayo L, Chronowski GM, Zafereo ME, Shah SJ. Impact of Cancer Care Regionalization on Patient Volume. Ann Surg Oncol 30(4):2331-2338, 2023. e-Pub 2022. PMID: 36581726.
- Snyder R, Gadot R, Gidley PW, Nader ME, Hanna EY, Su SY, DeMonte F, Raza SM. Patient, Disease, and Treatment-Related Factors Affecting Progression-Free and Disease-Specific Survival in Recurrent Chondrosarcomas of the Skull Base. Oper Neurosurg (Hagerstown) 24(1):33-43, 2023. e-Pub 2022. PMID: 36519877.
- Contrera KJ, Tam S, Pytynia K, Diaz EM, Hessel AC, Goepfert RP, Lango M, Su SY, Myers JN, Weber RS, Eguia A, Pisters PWT, Adair DK, Nair AS, Rosenthal DI, Mayo L, Chronowski GM, Zafereo ME, Shah SJ. ASO Visual Abstract: Impact of Cancer Care Regionalization on Patient Volume. Annals of Surgical Oncology 30(4):2341-2342, 2023. e-Pub 2023. PMID: 36720835.
- Habib A, Edem I, Bell D, Su SY, Hanna EY, Kupferman ME, DeMonte F, Raza SM. Soft Tissue Sarcomas of the Head and Neck Region with Skull Base/Intracranial Invasion: Review of Surgical Outcomes and Multimodal Treatment Strategies. A Retrospective Case Series. Curr Oncol 29(9):6540-6550, 2022. e-Pub 2022. PMID: 36135083.
- Schur S, Passer JZ, Hanna EY, Su SY, Kupferman ME, DeMonte F, Raza SM. The impact of expanded endoscopic approaches on oncologic and functional outcomes for clival malignancies: a case series. Journal of neuro-oncology 159(3):627-635, 2022. PMID: 35972674.
- Schur SE, Hanna EY, Su SY, Kupferman ME, DeMonte F, Raza SM. Impact of salvage surgery for recurrent sinonasal cancers with skull base and intracranial involvement. J Neurosurg:1-8. e-Pub 2022. PMID: 35120325.
- Kaya D, Garnes ND, Robins A, Su SY, Ginsberg, LE, Chen MM. Leprosy of the great auricular nerve: case report and review of the literature. Clinical Imaging 82:63-66, 2022. e-Pub 2021. PMID: 34775253.
- Ho J, Mattei J, Tetzlaff M, Williams MD, Davies MA, Diab A, Oliva ICG, McQuade J, Patel SP, Tawbi H, Wong MK, Fisher SB, Hanna E, Keung EZ, Ross M, Weiser R, Su SY, Frumovitz M, Meyer LA, Jazaeri A, Pettaway CA, Guadagnolo BA, Bishop AJ, Mitra D, Farooqi A, Bassett R, Faria S, Nagarajan P, Amaria RN. Neoadjuvant checkpoint inhibitor immunotherapy for resectable mucosal melanoma. Front Oncol 12:1001150, 2022. e-Pub 2022. PMID: 36324592.
- Diao K, Nguyen TP, Moreno AC, Reddy JP, Garden AS, Wang CH, Tung S, Wang C, Wang XA, Rosenthal DI, Fuller CD, Gunn GB, Frank SJ, Morrison WH, Shah SJ, Lee A, Spiotto MT, Su SY, Ferrarotto R, Phan J. Stereotactic body ablative radiotherapy for reirradiation of small volume head and neck cancers is associated with prolonged survival: Large, single-institution, modern cohort study. Head Neck 43(11):3331-3344, 2021. e-Pub 2021. PMID: 34269492.
- Mehta GU, Passer JZ, Raza SM, Kim BYS, Su SY, Kupferman ME, Hanna EY, DeMonte F. The neurosurgical management of sinonasal malignancies involving the anterior skull base: a 28-year experience at The MD Anderson Cancer Center. J Neurosurg(8):1-9. e-Pub 2021. PMID: 34624857.
- Abdelmeguid AS, Bell D, Roberts D, Ferrarotto R, Phan J, Su SY, Kupferman M, Raza S, DeMonte F, Hanna E. Long-Term Outcomes of Olfactory Neuroblastoma: MD Anderson Cancer Center Experience and Review of the Literature. The Laryngoscope 132(2):290-297. e-Pub 2021. PMID: 34272876.
- Abdelmeguid AS, Teeramatwanich W, Roberts DB, Amit M, Ferraroto R, Glisson BS, Kupferman ME, Su SY, Phan J, Garden AS, Raza SM, DeMonte F, Hanna EY. Neoadjuvant chemotherapy for locoregionally advanced squamous cell carcinoma of the paranasal sinuses. Cancer 127(11):1788-1795, 2021. e-Pub 2021. PMID: 33567468.
- Choi KY, Amit M, Tam S, Bell D, Phan J, Garden AS, Williams MD, Ferrarotto R, El-Naggar AK, Raza SM, DeMonte F, Kupferman ME, Hanna EY, Su SY. Clinical Implication of Diagnostic and Histopathologic Discrepancies in Sinonasal Malignancies. Laryngoscope 131(5):E1468-E1475, 2021. e-Pub 2020. PMID: 32946597.
- Ng SP, Wang H, Pollard C, Nguyen T, Bahig H, Fuller CD, Gunn GB, Garden AS, Reddy JP, Morrison WH, Shah S, Rosenthal DI, Frank SJ, Guha-Thakurta N, Ferrarotto R, Hanna EY, Su SY, Phan J. Patient Outcomes after Reirradiation of Small Skull Base Tumors using Stereotactic Body Radiotherapy, Intensity Modulated Radiotherapy, or Proton Therapy. J Neurol Surg B Skull Base 81(6):638-644, 2020. e-Pub 2019. PMID: 33381367.
- Habib A, Hanasono MM, DeMonte F, Haider A, Breshears JD, Nader ME, Gidley PW, Su SY, Hanna EY, Raza SM. Surgical Management of Skull Base Osteoradionecrosis in the Cancer Population - Treatment Outcomes and Predictors of Recurrence: A Case Series. Oper Neurosurg (Hagerstown) 19(4):364-374, 2020. e-Pub 2020. PMID: 32324878.
- Pasalic D, Ludmir EB, Allen PK, Thaker NG, Chapman BV, Hanna EY, Su SY, Ferrarotto R, Glisson BS, Reddy JP, Brandon Gunn G, Fuller CD, Phan J, Rosenthal DI, Morrison WH, Garden AS, Frank SJ. Patient-Reported Outcomes, Physician-Reported Toxicities, and Treatment Outcomes in a Modern Cohort of Patients with Sinonasal Cancer Treated Using Proton Beam Therapy. Radiother Oncol 148:258-266, 2020. e-Pub 2020. PMID: 32417351.
- Head MD, Guidelines Consortium NST, members C, Maniakas A, Jozaghi Y, Zafereo ME, Sturgis EM, Su SY, Gillenwater AM, Gidley PW, Lewis CM, Diaz E, Goepfert RP, Kupferman ME, Gross ND, Hessel AC, Pytynia KB, Nader ME, Wang JR, Lango MN, Kiong KL, Guo T, Zhao X, CMKL Y, Appelbaum E, Alpard J, Garcia JA, Terry S, Flynn JE, Bauer S, Fournier D, Burgess CG, Wideman C, Johnston M, You C, De Luna R, Joseph L, Diersing J, Prescott K, Heiberger K, Mugartegui L, Rodriguez J, Zendehdel S, Sellers J, Friddell RA, Thomas A, Khanjae SJ, Schwarzlose KB, Chambers MS, Hofstede TM, Cardoso RC, Wesson RA, Won A, Otun AO, Gombos DS, Al-Zubidi N, Hutcheson KA, Gunn GB, Rosenthal DI, Gillison ML, Ferrarotto R, Weber RS, Hanna EY, Myers JN, Lai SY. Head and neck surgical oncology in the time of a pandemic: Subsite-specific triage guidelines during the COVID-19 pandemic. Head Neck 42(6):1194-1201, 2020. PMID: 32342541.
- Amit M, Bell D, Hunt PJ, Hanna E, Su SY, Kupferman M, Aashiq M, Takahashi H, Gidley PW, Nader ME, DeMonte F, Raza SM. Surgical Management of Carcinomas of the Infratemporal Fossa and Skull Base: Patterns of Failure and Predictors of Long-Term Outcomes. J Neurosurg 134(5):1-7, 2020. e-Pub 2020. PMID: 32534492.
- Choi JS, Sansoni ER, Lovin BD, Lindquist NR, Phan J, Mayo LL, Ferrarotto R, Su SY. Abscopal Effect Following Immunotherapy and Combined Stereotactic Body Radiation Therapy in Recurrent Metastatic Head and Neck Squamous Cell Carcinoma: A Report of Two Cases and Literature Review. Ann Otol Rhinol Laryngol 129(5):3489419896602, 2020. e-Pub 2019. PMID: 31875405.
- Ng SP, Cardenas CE, Elhalawani H, Pollard C, Elgohari B, Fang P, Meheissen M, Guha-Thakurta N, Bahig H, Johnson JM, Kamal M, Garden AS, Reddy JP, Su SY, Ferrarotto R, Frank SJ, Brandon Gunn G, Moreno AC, Rosenthal DI, Fuller CD, Phan J. Comparison of tumor delineation using dual energy computed tomography versus magnetic resonance imaging in head and neck cancer re-irradiation cases. Phys Imaging Radiat Oncol 14:1-5, 2020. e-Pub 2020. PMID: 33458306.
- Abdelmeguid AS, Raza SM, Su SY, Kupferman M, Roberts D, DeMonte F, Hanna EY. Endoscopic Resection of Sinonasal Malignancies. Head Neck 42(4):645-652, 2020. e-Pub 2019. PMID: 31875340.
- Mesko S, Wang H, Tung S, Wang C, Pasalic D, Ning MS, Pezzi TA, Moreno AC, Reddy JP, Garden AS, Rosenthal DI, Gunn GB, Frank SJ, Fuller CD, Morrison W, Su SY, Hanna E, Phan J. Stereotactic Ablative Radiotherapy (SABR) for skull base malignancies: a systematic analysis of set-up and positioning accuracy. Pract Radiat Oncol. e-Pub 2020. PMID: 32240823.
- Bahig H, Ng SP, Pollard C, Nguyen TP, Gunn GB, Rosenthal DI, Fuller CD, Frank SJ, Garden AS, Reddy JP, Morrison WH, Ferrarotto R, Hanna EY, DeMonte F, Su SY, Phan J. A Prospective Evaluation of Health-Related Quality of Life after Skull Base Re-irradiation. Head Neck 42(3):485-497, 2020. e-Pub 2019. PMID: 31868271.
- Raza SM, Habib A, Wang WL, Gidley PW, Conley AP, Nader ME, Hanna EY, Su SY, DeMonte F. Surgical Management of Primary Skull Base Osteosarcomas: Impact of Margin Status and Patterns of Relapse. Neurosurgery nyz360(10.1093):360, 2020. e-Pub 2019. PMID: 31515560.
- Tyler MA, Mohamed ASR, Smith JB, Aymard JM, Fuller CD, Phan J, Frank SJ, Ferrarotto R, Kupferman ME, Hanna EY, Gunn GB, Su SY. Long-term quality of life after definitive treatment of sinonasal and nasopharyngeal malignancies. Laryngoscope 130(1):86-93, 2020. e-Pub 2019. PMID: 30706478.
- Hamza A, Roberts D, Su SY, Weber RS, Bell D, Ferrarotto R. PD-L1 Expression by Immunohistochemistry in Salivary Duct Carcinoma. Ann Diagn Pathol 40:49-52. e-Pub 2019. PMID: 30978575.
- Amit M, Abdelmeguid AS, Watcherporn T, Takahashi H, Tam S, Bell D, Ferrarotto R, Glisson B, Kupferman ME, Roberts DB, Su SY, Raza SM, DeMonte F, Hanna EY. Induction Chemotherapy Response as a Guide for Treatment Optimization in Sinonasal Undifferentiated Carcinoma. J Clin Oncol 37(6):800353, 2019. e-Pub 2019. PMID: 30615549.
- Mays AC, Hanna EY, Ferrarotto R, Phan J, Bell D, Silver N, Mulcahy CF, Roberts D, Abdelmeguid ASA, Fuller CD, Frank SJ, Raza SM, Kupferman ME, DeMonte F, Su SY. Prognostic Factors and Survival in Adenoid Cystic Carcinoma of the Sinonasal Cavity. Head Neck 40(12):2596-2605, 2018. e-Pub 2018. PMID: 30447126.
- Sagiv O, Bell D, Guo Y, Su SY, Wester ST, Jiang K, Yin VT, Shinder R, Hayek B, Kim HJ, Tetzlaff MT, Esmaeli B. Pathological Features and Clinical Course in Patients with Recurrent or Malignant Orbital Solitary Fibrous Tumor/Hemangiopericytoma. Ophthalmic Plast Reconstr Surg. e-Pub 2018. PMID: 30371551.
- Mehta GU, DeMonte F, Su SY, Kupferman ME, Hanna EY, Raza SM. Endoscopic endonasal transpterygoid transnasopharyngeal management of petroclival chondrosarcomas without medial extension. J Neurosurg:1-8. e-Pub 2018. PMID: 30074455.
- Ferrarotto R, Cardnell R, Su S, Diao L, Eterovic AK, Prieto V, Morrisson WH, Wang J, Kies MS, Glisson BS, Byers LA, Bell D. Poly ADP-ribose polymerase-1 as a potential therapeutic target in Merkel cell carcinoma. Head Neck 40(8):1676-1684, 2018. e-Pub 2018. PMID: 29570891.
- Amit M, Tam S, Abdelmeguid AS, Kupferman ME, Su SY, Raza SM, DeMonte F, Hanna EY. Patterns of Treatment Failure in Patients with Sinonasal Mucosal Melanoma. Ann Surg Oncol 25(6):1723-1729, 2018. e-Pub 2018. PMID: 29626308.
- Mays AC, Bell D, Ferrarotto R, Phan J, Roberts D, Fuller CD, Frank SJ, Raza SM, Kupferman ME, DeMonte F, Hanna EY, Su SY. Early Stage olfactory neuroblastoma and the impact of resecting dura and olfactory bulb. Laryngoscope 128(6):1274-1280, 2018. e-Pub 2017. PMID: 29226334.
- Raza SM, Gidley PW, Kupferman ME, Hanna EY, Su SY, DeMonte F. Site Specific Considerations in the Surgical Management of Skull Base Chondrosarcomas. Oper Neurosurg (Hagerstown) 14(6):611-619, 2018. e-Pub 2017. PMID: 28962038.
- Freeman JL, DeMonte F, Al-Holou W, Gidley PW, Hanna EY, Kupferman ME, Su SY, Raza SM. Impact of Early Access to Multi-Disciplinary Care on Treatment Outcomes in Patients with Skull Base Chordoma. Acta Neurochir (Wien) 160(4):731-740, 2018. e-Pub 2017. PMID: 29270681.
- Phan J, Pollard C, Brown PD, Guha-Thakurta N, Garden AS, Rosenthal DI, Fuller CD, Frank SJ, Gunn GB, Morrison WH, Ho JC, Li J, Ghia AJ, Yang JN, Luo D, Wang HC, Su SY, Raza SM, Gidley PW, Hanna EY, DeMonte F. Stereotactic Radiosurgery for Trigeminal Pain Secondary to Recurrent Malignant Skull Base Tumors. J Neurosurg 130(3):1-10, 2018. e-Pub 2018. PMID: 29701557.
- Amit M, Tam S, Abdelmeguid AS, Roberts DB, Raza SM, Su SY, Kupferman ME, DeMonte F, Hanna EY. Approaches to Regional Lymph Node Metastasis in Patients with Head and Neck Mucosal Melanoma. Cancer 124(3):514-520, 2018. e-Pub 2017. PMID: 29044491.
- Amit M, Tam S, Abdelmeguid AS, Kupferman ME, Su SY, Raza SM, DeMonte F, Hanna EY. Role of Adjuvant Treatment in Sinonasal Mucosal Melanoma. J Neurol Surg B Skull Base 78(6):512-518, 2017. e-Pub 2017. PMID: 29142805.
- Pollard C, Nguyen TP, Ng SP, Frank SJ, Garden AS, Gunn GB, Fuller CD, Beadle BM, Morrison WH, Shah SJ, Wang H, Tung S, Wang C, Ginsberg LD, Zafereo ME, Sturgis EM, Su SY, Hanna EY, Rosenthal DI, Phan J. Clinical outcomes after local field conformal reirradiation of patients with retropharyngeal nodal metastasis. Head Neck 39(10):2079-2087, 2017. e-Pub 2017. PMID: 28741749.
- Hansen CC, Smith JB, Mohamed ASR, Mulcahy CF, Wefel JS, Hutcheson KA, Chrane K, Phan J, Frank SJ, Garden AS, Smith BD, Eichelberger H, Anderson C, McCoy C, Horiates M, Patrick C, Floris S, French C, Beadle BM, Morrison WH, Su SY, Lewis CM, Kupferman ME, Johnson JM, Skinner HD, Lai SY, Hanna EY, Rosenthal DI, Fuller CD, Gunn GB, Head MD, Working Group NCS. Cognitive Function and Patient-Reported Memory Problem Following Radiation Therapy for Cancers at the Skull Base: A Survivorship Study Using the Telephone Interview for Cognitive Status and the MDASI-HN. Head Neck 39(10):2048-2056, 2017. e-Pub 2017. PMID: 28763137.
- Pollard C, Mesko SM, Ginsberg LE, Kies MS, Raza SM, Su SY, Tung S, Phan J. Nasopharyngeal carcinoma presenting as an inconspicuous primary lesion with extensive cavernous sinus involvement and temporal lobe extension: A case report and review of literature. Clin Case Rep 5(10):1682-1688, 2017. e-Pub 2017. PMID: 29026572.
- Su SY, Bell D, Ferrarotto R, Phan J, Roberts D, Kupferman ME, Frank SJ, Fuller CD, Gunn GB, Kies MS, Glisson BS, Hanna EY. Outcomes for olfactory neuroblastoma treated with induction chemotherapy. Head Neck 39(8):1671-1679, 2017. e-Pub 2017. PMID: 28561956.
- Amit M, Tam S, Abdelmeguid AS, Roberts DB, Takahashi Y, Raza SM, Su SY, Kupferman ME, DeMonte F, Hanna EY. Mutation status among patients with sinonasal mucosal melanoma and its impact on survival. Br J Cancer 116(12):1564-1571, 2017. e-Pub 2017. PMID: 28494469.
- Hunt PJ, DeMonte F, Tang RA, Su SY, Raza SM. Surgical Resection of an Optic Nerve Sheath Meningioma: Relevance of Endoscopic Endonasal Approaches to the Optic Canal. J Neurol Surg Rep 78(2):e81-e85, 2017. PMID: 28413768.
- Jiang W, Mohamed AS, Fuller CD, Kim BY, Tang C, Gunn GB, Hanna EY, Frank SJ, Su SY, Diaz E, Kupferman ME, Beadle BM, Morrison WH, Skinner H, Lai SY, El-Naggar AK, DeMonte F, Rosenthal DI, Garden AS, Phan J. The role of elective nodal irradiation for esthesioneuroblastoma patients with clinically negative neck. Pract Radiat Oncol 6(4):241-7, 2016. e-Pub 2015. PMID: 26979544.
- Holmes M, Su SY, Bell D. Ectopic primary olfactory neuroblastoma of the maxillary sinus. Ann Diagn Pathol 22:45-8, 2016. e-Pub 2016. PMID: 27180059.
- Horowitz PM, Su SY, Raza SM. Endoscopic Transclival Resection of Clival Chordoma Requiring Cavernous Sinus and Carotid Exposure. CSurgeries, 2016. PMID: None.
- Su SY, Milas ZL, Bhatt N, Roberts D, Clayman GL. Well differentiated thyroid cancer with aerodigestive tract invasion: Long-term control and functional outcomes. Head Neck 10(1):72-8, 2016. e-Pub 2015. PMID: 25204531.
- de Almeida JR, Carvalho F, Vaz Guimaraes Filho F, Kiehl TR, Koutourousiou M, Su SY, Vescan AD, Witterick IJ, Zadeh G, Wang EW, Fernandez-Miranda JC, Gardner PA, Gentili F, Snyderman CH. Comparison of endoscopic endonasal and bifrontal craniotomy approaches for olfactory groove meningiomas: A matched pair analysis of outcomes and frontal lobe changes on MRI. J Clin Neurosci 22(11):1733-41, 2015. e-Pub 2015. PMID: 26275331.
- de Almeida JR, Su SY, Koutourousiou M, Vaz Guimaraes Filho F, Fernandez Miranda JC, Wang EW, Gardner PA, Snyderman CH. Endonasal endoscopic surgery for squamous cell carcinoma of the sinonasal cavities and skull base: Oncologic outcomes based on treatment strategy and tumor etiology. Head Neck 23731(8):1163-9, 2015. e-Pub 2014. PMID: 24798497.
- Vaz-Guimaraes F, Su SY, Fernandez-Miranda JC, Wang EW, Snyderman CH, Gardner PA. Hemostasis in Endoscopic Endonasal Skull Base Surgery. J Neurol Surg B Skull Base 76(4):296-302, 2015. e-Pub 2015. PMID: 26225320.
- Su SY, Grodski S, Serpell J. "Hypothyroidism following hemithyroidectomy". Annals of Surgery 250(6):991-4, 2009. PMID: None.
- Su SY, Giorlando F, Ek EW, Dieu T. "Incomplete excision of basal cell carcinoma: a prospective trial". Plast Reconstr Surg 120(5):1240-8, 2007. PMID: 17898596.
- Tan PY, Ek E, Su SY, Giorlando F, Dieu T. "Incomplete excision of squamous cell carcinoma of the skin: a prospective observational study". Plast Reconstr Surg 120(4):910-6, 2007. PMID: 17805118.
- Ek EW, Giorlando F, Su SY, Dieu T. Clinical diagnosis of skin tumors: How good are we?. ANZ J Surg 75(6):415-20, 2005. PMID: 15943729.
- Goodman CD, DeMonte F, Nguyen TP, Garden AS, Wang CH, Wang XA, Diao K, Lee A, Reddy J, Moreno A, Spiotto M, Fuller CD, Rosenthal D, Ferrarotto R, Raza SM, Su SY, Warner A, Hanna EY, Phan J. “A prospective cohort study on stereotactic radiotherapy in the management of dural recurrence of olfactory neuroblastoma”. Head and Neck. PMID: None.
- Contrera KJ, Ferrarotto, R, Gunn GB, Su SY, Kies MS, Glisson BS, Garden AS, Roberts D, Williams MD, Raza SM, Demonte F, Chen MM, Chambers MS, Hanna EY. “Phase II Trial of Induction Chemotherapy for Advanced Sinonasal Squamous Cell Carcinoma”. Journal of Clinical Oncology. PMID: None.
- Snyder R, Rubino F, Seaman S, Banu M, Su SY, Hanna EY, DeMonte F, Raza SM. Impact of Previous Surgery and/or Radiation Therapy on Endoscopic Reconstruction Outcomes. Oper Neurosurg. PMID: None.
- Singh V, Khalaf A, Nguyen GK, Fagan R, Su SY, Learned KO, Hsieh KCJ. Imaging Evaluation of Sinonasal Tract Neoplasms. Mini-Invasive Surg. PMID: None.
Invited Articles
- Yaniv D, Su SY. Updates in management strategies of locally advanced sinonasal malignancy. Curr Opin Otolaryngol Head Neck Surg 31(1):39-44, 2023. e-Pub 2023. PMID: 36856185.
Other Articles
- Han AY, Nader ME, Lam K, Su SY Current status of sinonasal cancer survivorship care. Head Neck 45(9):2458-2468, 2023. PMID: 37449544.
- Hunt PJ, Amit M, Kabotyanski KE, Aashiq M, Hanna EY, Kupferman ME, Su SY, Gidley PW, Nader ME, DeMonte F, Raza SM Predictors of postoperative performance status after surgical management of infratemporal fossa malignancies. Neurosurg Rev 46(1):157, 2023. PMID: 37386212.
- Jozaghi Y, Phan J, Hanna EY, Kupferman ME, Su SY Functional Outcomes and Quality of Life in Patients with Sinonasal, Nasopharyngeal, and Anterior Skull Base Tumors. Curr Oncol Rep 24(6):775-781, 2022. PMID: 35290597.
- Yong M, Wu YQ, Su S, Hanna E, Prisman E, Thamboo A, Walgama E The effect of prior radiation on the success of ventral skull base reconstruction: A systematic review and meta-analysis. Head Neck. PMID: 33973680.
- Mehta GU, Raza SM, Su SY, Hanna EY, DeMonte F Management of olfactory neuroblastoma, neuroendocrine carcinoma, and sinonasal undifferentiated carcinoma involving the skullbase. J Neurooncol 150(3):367-375, 2020. PMID: 32424573.
- Ahmad FI, Su SY, Gross ND The Role of Sentinel Lymph Node Biopsy in the Management of Cutaneous Malignancies. Facial Plast Surg Clin North Am 27(1):119-129, 2019. PMID: 30420065.
- Horowitz PM, DiNapoli V, Su SY, Raza SM Complication Avoidance in Endoscopic Skull Base Surgery. Otolaryngol Clin North Am 49(1):227-35, 2016. PMID: 26614840.
- Su SY, Bell D, Hanna EY Esthesioneuroblastoma, Neuroendocrine Carcinoma, and Sinonasal Undifferentiated Carcinoma: Differentiation in Diagnosis and Treatment. Int Arch Otorhinolaryngol 18(Suppl 2):S149-S156, 2014. PMID: 25992139.
- Su SY, Kupferman ME, DeMonte F, Levine NB, Raza SM, Hanna EY Endoscopic Resection of Sinonasal Cancers. Curr Oncol Rep 16(2):369, 2014. PMID: 24445501.
Abstracts
- Pasalic D, Ludmir EB, Thaker NG, Allen PK, Gunn GB, Mesko S, Chapman BV, Hanna EY, Su SY, Ferrarotto R, Glisson BS, Reddy JP, Fuller CD, Phan J, Rosenthal DI, Morrison WH, Garden AS, Frank SJ. Prospective Patient-Reported Quality of Life, Toxicity, and Outcomes in Sinonasal Malignancies Treated Using Proton Beam Therapy. None, 2020. PMID: None.
- Amit M, Takahashi H, Hunt P, Su SY, Kupferman ME, Hanna EY, Demonte F, Raza SM. The Symptom Burden of Treatment Naïve Patients with Infratemporal Fossa Malignant Tumors. 29th North American Skull Base Society Annual Meeting, 2019. PMID: None.
- Bahig H, Ng SP, Pollard III C, Nguyen T, Gunn GB, Rosenthal DI, Frank SJ, Fuller CD, Garden AS, Reddy JP, Morrison WH, Ferrarrotto R, Hanna EY, De Monte F, Su SY, Phan J. A Prospective Evaluation of Health-Related Patient-Reported Outcomes after Skull Base Re- Irradiation. 29th North American Skull Base Society Annual Meeting, 2019. PMID: None.
- Choi KY, Amit M, Bell D, Harrison K, Phan J, Frank S, Ferrarroto R, Raza S, Demonte F, Kupferman M, Hanna E, Su SY. Clinical Implications of Histopathologic Diagnostic Discrepancies in Sinonasal Malignancies. 29th North American Skull Base Society Annual Meeting, 2019. PMID: None.
- Amit M, Takahashi H, Kupferman ME, Hunt P, Su SY, Demonte F, Hanna EY, Raza SM. Patterns of Treatment Failure in Patients with Infratemporal Fossa Malignancies. 29th North American Skull Base Society Annual Meeting, 2019. PMID: None.
- Mehta GU, Raza SM, Su SY, Kupferman ME, Hanna EY, Demonte F. Outcomes Of Surgical Management Of Sinonasal Malignancies Involving The Anterior Skull Base. 29th North American Skull Base Society Annual Meeting, 2019. PMID: None.
- Bahig H, Hanna EY, Garden AS, Ng SP, Frank SJ, Nguyen T, Gunn GB, Rosenthal DI, Fuller CD, Ferrarotto R, Bell D, Su SY, Phan J. Outcomes of Intensity Modulated Irradiation for Sinonasal Cancers: The MD Anderson Experience. 29th North American Skull Base Society Annual Meeting, 2019. PMID: None.
- Abdelmeguid AS, Raza SM, Kupferman ME, Su SY, Demonte F, Hanna EY. Endoscopic Resection of Sinonasal and Skull Base Malignancies. 29th North American Skull Base Society Annual Meeting, 2019. PMID: None.
- Mehta GU, DeMonte F, Su SY, Kupferman ME, Hanna EY, Raza SM. Endoscopic endonasal transpterygoid transnasopharyngeal management of petroclival chondrosarcomas without medial extension. Journal of Neurosurgery 10:1-8, 2018. PMID: 30074455.
- Raza SM, Gidley PW, Kupferman ME, Hanna EY, Su SY, DeMonte. Site-Specific Considerations in the Surgical Management of Skull Base Chondrosarcomas. Oxford Academic 6, 2018. PMID: 28962038.
- Tyler MA, Mohamed AS, Fuller CD, Phan J, Frank SJ, Ferrarotto R, Kupferman ME, Hanna EY, Su SY. Long Term Quality of Life in Patients Receiving Definitive Multimodality Treatment for Sinonasal Skull Base Malignancies. American Head and Neck Society, Annual Meeting at the Combined Otolaryngology Spring Meeting None(None):None, 2018. PMID: None.
- Abdelmeguid AS, Teeramatwanich W, Roberts DB, Amit M, Ferraroto R, Glisson BS, Kupferman ME, Su SY, Phan J, Garden AS, Raza SM, DeMonte F, Hanna EY. Long Term Outcomes of Management of Olfactory Neuroblastoma: MD Anderson Experience. J Neurol Surg B, 2018. PMID: None.
- Amit M, Hanna EY Abdelmeguid AS, Kupferman ME, Roberts D, Raza S, Demonte F, Amaria R, Su SY. Induction chemotherapy for chemoselection in advanced sinonasal mucosal melanoma. J Neurol Surg B, 2018. PMID: None.
- Ng SP, Wang H, Fuller CD, Gunn GB, Garden AD, Morrison W, Shah S, Hanna EY Su SY, Rosenthal D, Frank SJ, Phan J. Re-irradiation of Small Skull Base Tumors: A Comparison of Patient Outcomes after Stereotactic Body Radiotherapy (SBRT), Intensity Modulated Radiotherapy (IMRT), and Proton Therapy (PRT). J Neurol Surg B, 2018. PMID: None.
- Abdelmeguid AS, Teeramatwanich W, Roberts DB, Amit M, Ferraroto R, Glisson BS, Kupferman ME, Su SY, Phan J, Garden AS, Raza SM, DeMonte F, Hanna EY. Induction Chemotherapy for Sinonasal Squamous Cell Carcinoma. J Neurol Surg B, 2018. PMID: None.
- Ferrarotto R, Duran AH, Wei W, Carter BW, El-Naggar AK, Su SY, Bell D, Kies MS, Jr WW, Glisson BS, Godoy M, Heymach JV. Activating NOTCH1 mutations is associated with shorter progression-free survival to first-line systemic therapy in ACC. 2017 ASCO Annual Meeting, Chicago, IL, 2017. PMID: None.
- Mays AC, Hanna EY, Bell D, Ferrarotto R, Phan J, Su SY. Prognostic factors and survival in adenoid cystic carcinoma of the sinonasal cavity. AHNS 2017 Annual during the Combined Otolaryngology Spring Meetings (COSM), 2017. PMID: None.
- Ferrarotto R, Su SY, Diao L, Eterovic K, Prieto V, Morrisson WH, Wang J, Glisson BS, Kies MS, Bell D. PARP as a potential therapeutic target in merkel cell carcinoma. AHNS 2017 Annual during the Combined Otolaryngology Spring Meetings (COSM), 2017. PMID: None.
- Bell D, Su SY, Kies MS, Ferrarotto R. PARP1 Overexpression in Merkel Cell Carcinoma and Its Potential Clinical Implications. The United States & Canadian Academy of Pathology’s 106th Annual Meeting, San Antonio, TX, 2017. PMID: None.
- Su SY, Bell D, Ferrarotto R, Kupferman ME, Glisson BS, Kies MS, Hanna EY. Outcomes for esthesioneuroblastoma treated with neoadjuvant chemotherapy. AHNS 9th International Conference on Head and Neck Cancer, 2016. PMID: None.
- Raza SM, Hanna EY, Su SY, Kupferman ME, Gidley PM, DeMonte F. Temporal Bone chondrosarcoma. 7th International Congress of the World Federation of Skull Base Societies, 2016. PMID: None.
- deAlmeida JR, Carvalho F, Vaz-Guimaraes F, Koutourousiou M, Su, SY, Kiehl R, Vescan AD, Witterick IJ, Wang EW, Zadeh G, Fernandez-Miranda JC, Gardner PA, Gentili F, Snyderman CH. A comparison of post-operative MRI signal changes between endoscopic endonasal approaches and open approaches for olfactory groove meningiomas: a match paired analysis from two institutions. J Neurol Surg B 22(11):1733-41. e-Pub 2015. PMID: None.
- Su SY, Bell D, Kupferman ME, DeMonte F, Raza SM, Hanna EY. Early stage esthesioneuroblastoma, is resection of the cribriform dura and olfactory bulb necessary?. International Federation Head and Neck Surgery Conference, 2014. PMID: None.
- deAlmeida JR, Su SY, Vaz-Guimaraes F, Koutourousiou M, Wang FQ, Fernando-Miranda JC, Gardner PA, Snyderman CH. Endoscopic Endonasal Surgery for Squamous Cell Carcinoma of the Sinonasal Cavity and Skull Base. J Neurol Surg B 74 (suppl 1)(2), 2013. PMID: None.
- Su SY, de Almeida JR, Fernandez-Miranda JC, Gardner PA, Wang EW, Snyderman CH. Endoscopic Endonasal Resection of Sinonasal Undifferentiated Carcinoma: the UPMC experience. J Neurol Surg B 74 (suppl 1):2, 2013. PMID: None.
- Su SY, Le T, Roberts D, Kies M, Morrison W, Gillenwater A. Merkel Cell Carcinoma – the Effects of Site, Stage and Treatment on Recurrence and Survival. 8th International Conference on Head and Neck Cancer, 2012. PMID: None.
- Snyderman C, Wang E, Gardner E, Fernandez-Miranda J, Su SY. Skull Base Surgery: Open and Endoscopic Approaches for Adenocystic Carcinoma. 8th International Conference on Head and Neck Cancer, 2012. PMID: None.
- Snyderman C, Wang E, Gardner E, Fernandez-Miranda J, Su SY. Skull Base Surgery: Open and Endoscopic Approaches for Nasopharyngeal Carcinoma. 8th International Conference on Head and Neck Cancer, 2012. PMID: None.
- Vaz-Guimaraes F, Koutourousiou M, Su SY, deAlmeida JR, Fernandez-Miranda JC, Wang EW, Snyderman CH, Gardner PA. Endoscopic Endonasal Surgery for Suprasellar Meningiomas. North American Skull Base Society Meeting 2012, 2012. PMID: None.
Book Chapters
- Anderson JP, McMillan M, Su SY, Hutcheson K. Supportive Care for Patients with Sinonasal and Sinus Base Tumors. In: Sinonasal and Skull Base Malignancies. None. Springer Nature Publishers, 2022.
- Wang JR, Bell D, Ferrarotto R, Weber R, Su SY. Malignant Salivary Gland Tumors. In: Surgery of the Salivary Gland. None. Elsevier, 2021.
- Hanna EY, Raza SM, Su SY, Kupferman ME, DeMonte F. Surgical Management of Tumors of the Nasal Cavity, Paranasal Sinuses, Orbit, and Anterior Skull Base. In: Hanna/DeMonte, Comprehensive Management of Skull Base Tumors 2nd Edition. 2nd. Thieme Publishers, 2021.
- DeMonte F, Raza SM, Kupferman ME, Su SY, Nader ME, Gidley PW, Hanna EY. Clival Tumors. In: Hanna/DeMonte, Comprehensive Management of Skull Base Tumors 2nd Edition. None. Thieme Publishers, 2021.
- Hanna EY, Raza SM, Su SY, Kupferman ME, DeMonte F. Squamous Cell Carcinoma of the Nasal Cavity and Paranasal Sinuses. In: Comprehensive Management of Skull Base Tumor 2nd Edition. 2nd. Thieme Publishers, 2021.
- Su SY, Bell D. Sinonasal Mass & Malignant Sinonasal Tumors. In: Cases in Otolaryngology Head and Neck Surgery and Audiology. None. Anadem Publishing, 2019.
- Hanna EY, Su SY, Kupferman ME, Raza SM, DeMonte F. Cancer of the Nasal Cavity and Paranasal Sinuses. In: Cancers of the Head and Neck. 5th. None, 2016.
- Eguia A, Su SY. Mucosal melanomas of the Head and Neck. In: In Goldenberg: Handbook of Otolaryngology: Head and Neck Surgery, 3rd Edition. None. Elsevier.
Selected Presentations & Talks
Regional Presentations
- 2005. Incomplete Excision of Basal Cell Carcinoma: A Prospective Trial. Conference. Royal Australian College of Surgeons, Victorian Annual General, Scientific and Fellowship Meeting. Ballarat, Australia, US.
National Presentations
- 2025. Survivorship Issues in Sinonasal and Nasopharyngeal Cancers - What Every Head and Neck Surgeon Needs to Know. Panelist. 2025 AHNS Annual Meeting. New Orleans, Louisiana, US.
- 2025. Women`s Panel: The 7-year Itch - Exploring Leadership and Alternative Career Pathway to Academic Medicine. Panelist. 2025 AHNS Annual Meeting. New Orleans, Lousiana, US.
- 2025. Research Advances: Addressing Treatment Challenges With Anterior Skull Base Tumors. Panelist. Triological Society 2025 Combined Sections Meeting. Orlando, Florida, US.
- 2024. Podium Presentation: Open and Endoscopic Transpterygoid Approach to the Skull Base. Conference. Summer Dissection Course. New Orleans, LA, US.
- 2024. Moderator: Women in Head and Neck Surgery – How to Build Impactful Programs. Conference. American Head and Neck Society Annual Meeting at the Combined Otolaryngology Spring Meeting. Chicago, IL, US.
- 2024. Moderator: Surgical Approach for Sinonasal Tumors. Conference. North American Skull Base Society. Atlanta, GA, US.
- 2024. Podium Presentation: ICAR-Evidence Based Management of Sinonasal Undifferentiated Carcinoma. Conference. North American Skull Base Society. Atlanta, GA, US.
- 2023. Virtual Presentation, “Sinonasal Malignancy – Challenges and Opportunities”. Conference. Department of Otolaryngology Head and Neck Surgery Virtual Grand Rounds Lecture. Philadelphia, PA, US.
- 2023. Podium Presentation, “Anatomy of Infratemporal Fossa and Parapharyngeal Space” Comprehensive Skull Base Course: Multidisciplinary Surgical Approaches. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
- 2023. Podium Presentation, “Skull Base Pathologies” Comprehensive Skull Base Course: Multidisciplinary Surgical Approaches. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
- 2023. Faculty, Comprehensive Skull Base Course: Multidisciplinary Surgical Approaches. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
- 2023. Podium Presentation: Expert Series “Evidence Based Approach to Sinonasal Cancers”. Conference. 127th AAO-HNSF Annual Meeting & OTO Experience. Nashville, TN, US.
- 2023. Podium Presentation in Panel: “Managing Surgical Complications: Skull Base Perspective for the Comprehensive Otolaryngologist”. Conference. 127th AAO-HNSF Annual Meeting & OTO Experience. Nashville, TN, US.
- 2023. Podium Presentation: Functional Considerations in the Endoscopic Approaches to the Pituitary and Skull Base. Conference. 127th AAO-HNSF Annual Meeting & OTO Experience. Nashville, TN, US.
- 2023. Panelist: Skull Base Tumor Board, Joint American Head and Neck Society & American Rhinology Society Fellow Lecture Series. Conference. American Head and Neck Society & American Rhinology Society. Nashville, TN, US.
- 2023. Podium Presentation and Moderator, “Head and Neck and Skull Base Tumor Board” Survivorship after Cancer of the Head and Neck: A Multidisciplinary Symposium. Conference. The University of Pittsburgh Medical Center. Pittsburgh, PA, US.
- 2023. Keynote Speaker, “Development of a Validated Disease Specific Tool for Cancer Survivors” Survivorship after Cancer of the Head and Neck: A Multidisciplinary Symposium. Conference. The University of Pittsburgh Medical Center. Pittsburgh, PA, US.
- 2023. Zoom Presentation: Surgical Management of Sinonasal Tumors. Conference. Department of Radiation Oncology Grand Rounds. Houston, TX, US.
- 2023. Expert Debate Panelist: Endonasal vs Transorbital vs Transcranial Approaches for Anterior Skull Base Meningioma. Invited. North American Skull Base Society Annual Meeting. Tampa, FL, US.
- 2023. Moderator: Proffered papers: head and neck/reconstruction. Invited. North American Skull Base Society Annual Meeting. Tampa, FL, US.
- 2022. Podium Presentation- Sinonasal Malignancy – Challenges and Opportunities. Invited. University of Pittsburgh Medical Center, Department of Otolaryngology, Head and Neck Surgery, Grand Rounds Lecture. Pittsburgh, PA, US.
- 2022. Guest Faculty: Comprehensive Endoscopic Endonasal Surgery of the Skull Base Course. Conference. University of Pittsburgh Medical Center. Pittsburgh, PA, US.
- 2022. Panelist- Management of Head and Neck and Skull Base Adenoid Cystic Carcinoma. Invited. Adenoid Cystic Carcinoma Research Foundation. Virtual Webinar, US.
- 2022. Panelist- Sinonasal Malignancy Virtual Tumor Board. Invited. Sinonasal Cancer Collaborative, Tri-society collaboration of American Rhinologic Society, North American Skull Base Society and American Head and Neck Society. Virtual webinar, US.
- 2022. Podium Presentation, Expert Series- Evidence Based Approach to Sinonasal Cancers. Conference. 126th AAO-HNSF Annual Meeting & OTO Experience. Philadelphia, PA, US.
- 2022. Podium Presentation in Panel: Managing Surgical Complications: Skull Base Perspective for the Comprehensive Otolaryngologist. Conference. 126th AAO-HNSF Annual Meeting & OTO Experience. Philadelphia, PA, US.
- 2022. Podium Presentation: Functional Considerations in the Endoscopic Approaches to the Pituitary and Skull Base. Conference. 126th AAO-HNSF Annual Meeting & OTO Experience. Philadelphia, PA, US.
- 2022. Podium Presentation, Endoscopic Management of the Optic Nerve. Conference. 126th AAO-HNSF Annual Meeting & OTO Experience. Philadelphia, PA, US.
- 2022. Moderator, Scientific Oral Presentations 5. Invited. Head and Neck Surgery 126th AAO-HNSF Annual Meeting & OTO Experience. Philadelphia, PA, US.
- 2022. Podium Presentation: Endoscopic endonasal approach to the sella and supra-sella. Invited. North American Skull Base Society Summer Dissection Course. New Orleans, LA, US.
- 2022. Podium Presentation and Moderator- Advanced Non-Melanoma Skin Cancer: The Role of Sentinel Lymph Node Biopsy?. Invited. American Head and Neck Society Annual Meeting at the Combined Otolaryngology Spring Meeting. Dallas, TX, US.
- 2022. Moderator- Exploring Technological Advances in Skull Base Surgery. Invited. American Head and Neck Society Annual Meeting at the Combined Otolaryngology Spring Meeting. Dallas, TX, US.
- 2022. Moderator- Advanced Non-Melanoma Skin Cancer: New Diagnostics, Therapies, and Techniques. Conference. American Head and Neck Society. Dallas, TX, US.
- 2022. Virtual Presentation- Multimodality Treatment of Advanced Squamous Cell Carcinoma of the Head and Neck. Invited. The University of Texas at Tyler Health Science Center, Grand Rounds Lecture. Tyler, TX, US.
- 2022. Panelist: Sinonasal Malignancies T4b (Infratemporal Fossa and Skull Base Involvement) - Surgery vs Neoadjuvant. Invited. North American Skull Base Society Annual Meeting. Phoenix, AZ, US.
- 2022. Panel: Sinonasal Malignancies T4b (Infratemporal Fossa and Skull Base Involvement) Surgery vs neoadjuvant. Invited. North American Skull Base Society Annual Meeting. Phoenix, AZ, US.
- 2022. Podium Presentation, "Sinonasal Malignancies with Skull Base Involvement, Induction Chemotherapy for Esthesioneuroblastoma - When and Why?". Invited. North American Skull Base Society Annual Meeting. Phoenix, AZ, US.
- 2021. Virtual Presentation- Induction chemotherapy in the treatment of sinonasal malignancy. Invited. University of Toronto Department of Otolaryngology Head and Neck Surgery, Grand Rounds Lecture. Toronto, Canada, US.
- 2021. Faculty - Sinonasal and Skull Base Tumors, AHNS/AAO Head and Neck Surgery Symposium for Residents and Fellows Review Course, in conjunction with AAO-HNSF Annual Meeting and OTO Expo. Invited. 125th AAO-HNSF 2020 Annual Meeting & OTO Experience. Los Angeles, CA, US.
- 2021. Virtual Presentation: Functional Considerations in the Endoscopic Approach to the Pituitary. Conference. 125th AAO-HNSF 2020 Annual Meeting & OTO Experience. Los Angeles, CA, US.
- 2021. Virtual Presentation and Panelist: Controversies in Skull Base Surgery. Conference. 125th AAO-HNSF Annual Meeting & OTO Experience. Los Angeles, CA, US.
- 2021. Virtual Presentation: Endoscopic Management of the Optic Nerve. Conference. 125th AAO-HNSF 2020 Annual Meeting & OTO Experience. Los Angeles, CA, US.
- 2021. Virtual Presentation: Managing Surgical Complications: Skull Base Perspective for the Comprehensive Otolaryngologist. Conference. 125th AAO-HNSF 2020 Annual Meeting & OTO Experience. Los Angeles, CA, US.
- 2021. Panel/Virtual Presentation: Controversies in Skull Base Surgery. Conference. 125th AAO-HNSF 2020 Annual Meeting & OTO Experience. Los Angeles, CA, US.
- 2021. Virtual Presentation, “Updates in the Management of Sinonasal Malignancy”. Conference. Baylor Scott and White Oncology Grand Rounds. Dallas, TX, US.
- 2021. Virtual Presentation, “State of the Art of Treatment of Sinonasal Malignancy”. Conference. 2021 Otolaryngology Virtual Updates Course, US.
- 2020. Endoscopic Approach to Anterior Skull Base. Invited. Virtual: North American Skull Base Society Dissection Course Meeting. New Orleans, LA, US.
- 2020. Co-Chair, Head & Neck Session, MD Anderson Cancer Center Global Academic Programs (GAP) and Peter MacCallum Cancer Centre. Conference. MD Anderson Cancer Center Global Academic Programs (GAP) and Peter MacCallum Cancer Centre. Melbourne, US.
- 2020. Functional Considerations in Skull Base Surgery. Invited. The University of Texas MD Anderson Cancer Center, Division of Surgery Grand Rounds. Houston, TX, US.
- 2020. Virtual Presentation: Endoscopic Management of the Optic Nerve. Conference. American Academy of Otolaryngology Head and Neck Surgery Foundation Annual & OTO Experience, US.
- 2020. Virtual Meeting: Complication Avoidance in Skull Base Surgery. Conference. American Academy of Otolaryngology Head and Neck Surgery Foundation Annual & OTO Experience, US.
- 2020. Virtual Presentation: Functional Considerations in the Endoscopic Approach to the Pituitary. Conference. American Academy of Otolaryngology Head and Neck Surgery Foundation Annual & OTO Experience, US.
- 2020. Expert Debate 7: Medical Advances in the Management of Skull Base Tumors – Current and Future Therapies. Invited. North American Skull Base Society Annual Meeting. San Antonio, TX, US.
- 2020. Induction Chemotherapy for Olfactory Neuroblastoma. Invited. North American Skull Base Society. San Antonio, TX, US.
- 2020. Podium Presentation, “Medical and Molecular Advances in Skull Base Tumor Management – Current and Future”. Conference. North American Skull Base Society. San Antonio, TX, US.
- 2019. How I Do It - Endoscopic Approach to the Pituitary and Skull Base. Invited. Current Concepts in Head and Neck Surgery. Houston, TX, US.
- 2019. Endoscopic Management of the Optic Nerve. Conference. 2019 American Academy of Otolaryngology Head and Neck Surgery Foundation Annual Meeting & OTO Experience. New Orleans, LA, US.
- 2019. Skull Base Cancer Debate: Should I Operate?. Invited. 2019 American Head and Neck Society Annual Meeting at Combined Otolaryngology Spring Meeting. Austin, TX, US.
- 2018. Faculty, Comprehensive Skull Base Course: Indications for Open and Endoscopic Approaches in the Management of Complex Benign and Malignant Pathology. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
- 2018. Long Term Quality of Life in Patients Receiving Definitive Multimodality Treatment for Sinonasal Skull Base Malignancies. Conference. Triological Society. National Harbor, MD, US.
- 2018. The Implications of Pathology in the Management of Sinonasal Malignancies. Invited. American Head and Neck Society at the Combined Otolaryngology Societies Meeting (COSM). National Harbor, MD, US.
- 2018. Panel: Sinonasal Malignancies. Invited. 28th North American Skull Base Society Meeting. San Diego, CA, US.
- 2018. Sinonasal Cancer – Surgical vs Non-Surgical Management. Invited. North American Skull Base Society Annual Meeting. San Diego, CA, US.
- 2018. Infratemporal Fossa Endoscopic Dissection Duel – How I Do It. Invited. 28th North American Skull Base Society Meeting. San Diego, CA, US.
- 2017. Management of Recurrent Sinonasal Malignancy. Invited. 27th North American Skull Base Society Meeting. New Orleans, LA, US.
- 2017. Endoscopic Approaches to the Skull Base and Orbit. Invited. Advances in Orbital Oncology and Oculofacial Plastic Surgery: A Multidisciplinary Approach. Houston, TX, US.
- 2016. Moderator - Current Concepts in Head and Neck Surgery - Salivary Glands and Skull Base. Invited. MD Anderson Cancer Center. Houston, TX, US.
- 2015. Endoscopic Approaches to the Skull Base and Orbit. Invited. Advances in Orbital Oncology and Oculofacial Plastic Surgery: A Multidisciplinary Approach. Houston, TX, US.
- 2012. Endoscopic Endonasal Resection of Sinonasal Undifferentiated Carcinoma: the UPMC Experience. Conference. North American Skull Base Society. Miami, FL, US.
- 2012. Outcomes for Endoscopic Endonasal Resection of Adenocystic Carcinoma of the Sinonasal Cavity and Skull Base. Conference. North American Skull Base Society. Miami, FL, US.
International Presentations
- 2024. Panelist: International Consensus Statement on Sinonasal Tumors – Sinonasal Undifferentiated Carcinomas. Conference. American Head and Neck Society Annual Meeting at the Combined Otolaryngology Spring Meeting. Chicago, US.
- 2024. Keynote Lecture: Advances in Histology Specific Treatment for Sinonasal Malignancies. Invited. The Singapore Head and Neck Society and the Tri-Society Head and Neck Oncology Conference, SG.
- 2024. Podium Presentation “Quality of Life in Sinonasal Malignancy Survivors”. Invited. The Singapore Head and Neck Society and the Tri-Society Head and Neck Oncology Conference, SG.
- 2024. Podium Presentation, " Management of the Orbit in Sinonasal Malignancy". Conference. The Singapore Head and Neck Society and the Tri-Society Head and Neck Oncology Conference, SG.
- 2023. Instructional Course, “State of the Art in Management of Advanced Skull Base Malignancies”. Invited. 11th International Conference on Head and Neck Cancer. Montreal, CA.
- 2023. Podium Presentation and Panelist: Mucosal Melanoma Multidisciplinary Management of Challenging Skull Base Tumors. Invited. 7th World Congress of the International Federation of Head and Neck Oncologic Societies. Rome, IT.
- 2021. Virtual Presentation: The NPC and Skull Base Surgery: Complex Case Discussion. Invited. American Head and Neck Society 10th International Conference on Head and Neck Cancer. Chicago, US.
- 2021. Meeting cancelled due to Covid: The NPC and Skull Base Surgery: Complex Case Discussion. Invited. American Head and Neck Society 10th International Conference on Head and Neck Cancer. Chicago, US.
- 2021. Poster/Virtual Presentation: Pituitary Dysfunction Following Radiotherapy for Sinonasal and Nasopharyngeal Malignancies. Conference. American Head and Neck Society 10th International Conference on Head and Neck Cancer. Chicago, US.
- 2021. Poster/Virtual Presentation: Neurocognitive Functioning of Patients with Sinonasal and Nasopharyngeal Cancers Treated with Multimodality Therapy. Conference. American Head and Neck Society 10th International Conference on Head and Neck Cancer. Chicago, US.
- 2021. Panel/Virtual Presentation: Controversies in Skull Base Surgery. Invited. American Head and Neck Society International Virtual Tumor Board, US.
- 2020. The NPC and Skull Base Surgery: Complex Case Discussion. Invited. Cancelled due to Covid: American Head and Neck Society 10th International Conference on Head and Neck Cancer. Chicago, US.
- 2016. Outcomes for Esthesioneuroblastoma Treated with Neoadjuvant Chemotherapy. Conference. American Head and Neck Society 9th International Conference on Head and Neck Cancer. Seattle, US.
- 2014. Early Stage Esthesioneuroblastoma, is Resection of the Cribriform Dura and Olfactory Bulb Necessary?. Conference. International Federation Head & Neck Surgery Conference. New York City, US.
- 2012. Merkel Cell Carcinoma – the Effects of Site, Stage and Treatment on Recurrence and Survival. Conference. 8th International Conference on Head and Neck Cancer. Toronto, CA.
- 2009. Poster: Vocal Cord Paralysis Following Permacath Insertion. Conference. 58th Annual Scientific Meeting of the Australian Society of Otolaryngology Head and Neck Surgery. Gold Coast, AU.
- 2007. Hypothyroidism Following Hemithyroidectomy. Conference. Royal Australasian College of Surgeons Annual Scientific Congress. Christchurch, NZ.
- 2006. A Randomized, Placebo-controlled Trial of Rectus Sheath Local Anesthetic Infusion after Major Abdominal Surgery. Conference. Royal Australian College of Surgeons Annual Scientific Congress. Sydney, AU.
Formal Peers
- 2023. Sinonasal Malignancy – Current State of the Art. Visiting. University of Pennsylvania. Philadelphia, PA, US.
- 2023. Development with a Validated Disease Specific Tool for Cancer Survivors. Invited. University of Pittsburgh Medical Center. Pittsburgh, PA, US.
- 2023. Moderator- Panel Discussion: Tumor Board. Invited. University of Pittsburgh Medical Center. Pittsburgh, PA, US.
- 2022. Podium Presentation, “Skull Base Pathology”. Visiting. Baylor College of Medicine. Houston, TX, US.
- 2021. Virtual presentation: Induction Chemotherapy in the Treatment of Sinonasal Malignancy. Visiting. University of Toronto Department of Otolaryngology Head and Neck Surgery, Grand Rounds Lecture. Toronto, Ontario, CA.
- 2021. Updates in Management of Sinonasal Malignancy. Visiting. Baylor Scott and White Oncology Grand Rounds. College Station, TX, US.
- 2021. Virtual presentation: Induction Chemotherapy for Sinonasal Malignancy. Visiting. University of Pittsburgh Medical Center, Department of Head and Neck Surgery - Grand Rounds Lecture. Pittsburgh, PA, US.
- 2021. Virtual Presentation: State of the Art of Treatment of the Sinonasal Malignancy. Invited. Combined University of California - Irvine, Asan Medical Center (Korea), and University of Hamburg (UKE). Irvine, CA, US.
- 2020. Panelist/Virtual Meeting: Management of Sinonasal Tumors. Invited. University of California San Francisco Head and Neck Cancer Course. San Francisco, CA, US.
- 2020. Virtual Presentation: Management of Advanced Cutaneous Non-melanoma Malignancies. Invited. University of California San Francisco Head and Neck Cancer Course. San Francisco, CA, US.
Grant & Contract Support
| Title: | Defining Symptom Burden and Quality of Life in Patients Treated with Skull Base Tumor |
| Funding Source: | Oliver S. and Jennie R. Donaldson Charitable Trust |
| Role: | PI |
| Title: | MD Anderson symptom inventory, skull base module: developing a disease specific instrument to evaluate quality of life in patients with skull base tumors |
| Funding Source: | Cancer Survivorship Research Seed Money Grants at the University of Texas MD Anderson Cancer Center |
| Role: | PI |
| Title: | PRO-ACTIVE Comparing the Effectiveness of Prophylactic Swallow Intervention for Patients Receiving Radiotherapy for Head and Neck Cancer |
| Funding Source: | Patient-Centered Outcomes Research Institute |
| Role: | Collaborator |
Patient Reviews
CV information above last modified January 06, 2025